COLL vs. HQY
COLL (Collegium Pharmaceutical, Inc.) and HQY (HealthEquity, Inc.) are both stocks. Both are in the Healthcare sector — COLL in Drug Manufacturers - Specialty & Generic, HQY in Health Information Services. Over the past 10 years, COLL returned 11.44%/yr vs 13.73%/yr for HQY. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
COLL vs. HQY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, COLL achieves a -23.15% return, which is significantly lower than HQY's 13.92% return. Over the past 10 years, COLL has underperformed HQY with an annualized return of 11.44%, while HQY has yielded a comparatively higher 13.73% annualized return.
COLL
- 1D
- 0.54%
- 1M
- -3.92%
- 6M
- -24.47%
- YTD
- -23.15%
- 1Y
- 18.32%
- 3Y*
- 14.84%
- 5Y*
- 7.36%
- 10Y*
- 11.44%
- ALL TIME*
- 10.15%
HQY
- 1D
- 3.73%
- 1M
- 9.50%
- 6M
- 19.86%
- YTD
- 13.92%
- 1Y
- 14.61%
- 3Y*
- 15.94%
- 5Y*
- 7.72%
- 10Y*
- 13.73%
- ALL TIME*
- 14.75%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $10.12M | $13.25M | $14.94M | |
| $71.97M | $73.40M | $84.68M |
COLL vs. HQY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COLL Collegium Pharmaceutical, Inc. | -23.15% | 61.61% | -6.92% | 32.67% | 24.20% | -6.74% | -2.67% | 19.86% | -6.99% | 18.56% |
HQY HealthEquity, Inc. | 13.92% | -4.52% | 44.72% | 7.56% | 39.33% | -36.54% | -5.89% | 24.17% | 27.84% | 15.15% |
Correlation
The correlation between COLL and HQY is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.24 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.24 |
Correlation (All Time) Calculated using the full available price history since May 7, 2015 | 0.23 |
Fundamentals
COLL:
$1.15B
HQY:
$8.72B
COLL:
$1.89
HQY:
$2.67
COLL:
18.86
HQY:
39.12
COLL:
0.45
HQY:
0.28
COLL:
1.78
HQY:
6.75
COLL:
4.56
HQY:
4.33
COLL:
$796.33M
HQY:
$1.34B
COLL:
$483.18M
HQY:
$972.12M
COLL:
$550.27M
HQY:
$300.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COLL vs. HQY — Risk / Return Rank
COLL
HQY
COLL vs. HQY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and HealthEquity, Inc. (HQY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COLL | HQY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.04 | ||
| Sortino ratioReturn per unit of downside risk | +0.18 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.10 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.47 | 0.48 | -0.01 |
| Martin ratioReturn relative to average drawdown | 0.89 | 0.94 | -0.05 |
Loading charts...
Drawdowns
COLL vs. HQY - Drawdown Comparison
The maximum COLL drawdown since its inception was -73.59%, which is greater than HQY's maximum drawdown of -60.65%. Use the drawdown chart below to compare losses from any high point for COLL and HQY.
Loading charts...
Drawdown Indicators
| COLL | HQY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.59% | -60.65% | -12.94% |
Max Drawdown (1Y)Largest decline over 1 year | -38.84% | -30.57% | -8.27% |
Max Drawdown (3Y)Largest decline over 3 years | -41.07% | -36.07% | -5.00% |
Max Drawdown (5Y)Largest decline over 5 years | -42.75% | -46.30% | +3.55% |
Max Drawdown (10Y)Largest decline over 10 years | -65.22% | -60.65% | -4.57% |
Current DrawdownCurrent decline from peak | -28.61% | -8.86% | -19.75% |
Average DrawdownAverage peak-to-trough decline | -31.13% | -22.95% | -8.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.65% | 15.59% | +5.06% |
Volatility
COLL vs. HQY - Volatility Comparison
The current volatility for Collegium Pharmaceutical, Inc. (COLL) is 8.41%, while HealthEquity, Inc. (HQY) has a volatility of 9.62%. This indicates that COLL experiences smaller price fluctuations and is considered to be less risky than HQY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| COLL | HQY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 9.62% | -1.21% |
Volatility (6M)Calculated over the trailing 6-month period | 27.39% | 25.50% | +1.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.56% | 35.43% | +5.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.58% | 39.90% | +0.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.84% | 44.57% | +9.27% |
Dividends
COLL vs. HQY - Dividend Comparison
Neither COLL nor HQY has paid dividends to shareholders.
Financials
COLL vs. HQY - Financials Comparison
This section allows you to compare key financial metrics between Collegium Pharmaceutical, Inc. and HealthEquity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
COLL vs. HQY - Profitability Comparison
COLL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Collegium Pharmaceutical, Inc. reported a gross profit of 117.25M and revenue of 193.52M. Therefore, the gross margin over that period was 60.6%.
HQY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, HealthEquity, Inc. reported a gross profit of 256.31M and revenue of 354.64M. Therefore, the gross margin over that period was 72.3%.
COLL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Collegium Pharmaceutical, Inc. reported an operating income of 30.90M and revenue of 193.52M, resulting in an operating margin of 16.0%.
HQY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, HealthEquity, Inc. reported an operating income of 102.95M and revenue of 354.64M, resulting in an operating margin of 29.0%.
COLL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Collegium Pharmaceutical, Inc. reported a net income of 14.50M and revenue of 193.52M, resulting in a net margin of 7.5%.
HQY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, HealthEquity, Inc. reported a net income of 69.42M and revenue of 354.64M, resulting in a net margin of 19.6%.
Frequently Asked Questions
COLL and HQY have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HQY has higher volatility (9.62%) compared to COLL (8.41%). In terms of maximum drawdown, COLL dropped -73.59% vs HQY's -60.65%.
COLL currently has the higher Sharpe Ratio (0.45 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for COLL and HQY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer